U.S. Capital Markets Stock News

NasdaqGS:NOVT
NasdaqGS:NOVTElectronic

Novanta (NOVT) Could Be 6% Undervalued Following Its Shelf Registration

Novanta (NOVT) has filed a shelf registration for up to 2,142,857 common shares, totaling about US$337.6 million. This filing gives the company flexibility to raise equity capital for future corporate uses. See our latest analysis for Novanta. At a share price of US$164.89, Novanta has seen a 48.36% year to date share price return and a 28.02% total shareholder return over one year. The recent 43.03% 90 day share price return suggests momentum has been building ahead of and around the shelf...
NYSEAM:SEB
NYSEAM:SEBFood

Seaboard (SEB) Index Exit Puts Its Cheap P E And Fair Value Debate In Focus

Index removals put Seaboard in focus Seaboard (SEB) has been removed from both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index. This change can prompt index-tracking funds to adjust positions and reassess exposure. See our latest analysis for Seaboard. Following its index removals, Seaboard’s share price has fallen 18.43% over the past 30 days and 23.19% over the past 90 days. The 1-year total shareholder return is 47.42%, indicating longer term holders have still...
NYSE:MAS
NYSE:MASBuilding

Ferguson Stock And 2 U.S. Export Picks Tied to New Trade Deals

The U.S. Industrial Exporters screener focuses on companies that sit right where trade policy meets real-world revenue. With a new U.S.-EU agreement, questions around USMCA, and ongoing U.S.-China tensions, these exporters face both fresh openings and added friction in key markets. For investors, that mix of risk and potential reward can make careful stock selection more important than ever. This article walks through 3 stocks from the screener that appear positively exposed to the latest...
NYSE:WS
NYSE:WSMetals and Mining

Worthington Steel (WS) Is Down 7.2% After Major Impairment-Driven Loss and New Credit Facility - What's Changed

Worthington Steel, Inc. recently reported fourth-quarter 2026 results showing sales of US$929.2 million but a net loss of US$48.7 million, driven largely by US$94.5 million of goodwill and long-lived asset impairment charges. Around the same time, the company refinanced its asset-based revolving credit facility with a new agreement of up to US$550.0 million and affirmed a US$0.16 quarterly dividend, signaling an effort to balance balance-sheet flexibility with continued cash returns to...
NYSE:EVC
NYSE:EVCMedia

Why Entravision Communications (EVC) Is Down 6.7% After Removal From Key Russell Value Indices

In late June 2026, Entravision Communications Corporation (NYSE:EVC) was removed from several major Russell value and small‑cap benchmarks, including the Russell 2000 Value and Russell 3000 Value indices. This broad index removal can matter because many index‑tracking and benchmark‑aware funds may adjust their holdings, potentially reshaping how the company fits into diversified portfolios. We will now examine how Entravision’s removal from multiple Russell value indices influences its...
NasdaqCM:SHAZ
NasdaqCM:SHAZIT

How Investors May Respond To SharonAI Holdings (SHAZ) Russell Index Debut And $1.6 Billion NVIDIA Deal

In late June 2026, SharonAI Holdings Inc. (NasdaqCM: SHAZ) was added to multiple Russell indices and closed an oversubscribed US$1.60 billion private placement to help fund a six-year compute collaboration with NVIDIA, including plans for an AI factory in Australia using up to 40,000 Grace Blackwell GB300 GPUs. The combination of broad Russell index inclusion and backing from institutional investors such as Situational Awareness L.P. and Oaktree Capital Management L.P. signals growing...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

VEON (VEON) Expands Digital Finance And AI Infrastructure, Is It Still 36% Undervalued?

VEON (NasdaqGS:VEON) is back in focus after two recent technology partnerships: a Mastercard collaboration on digital finance across several core markets and a Ukraine focused memorandum on AI ready data infrastructure. See our latest analysis for VEON. VEON’s recent announcements around digital finance and AI ready infrastructure come as momentum has picked up in the stock, with an 11.45% 90 day share price return and a 22.82% 1 year total shareholder return. The 3 year total shareholder...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

US Stock Market Today: S&P 500 Futures Rise As Inflation Worries Ease

The Morning Bull - US Market Morning Update Tuesday, Jul, 7 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.4% and Nasdaq-100 futures ahead almost 1%, as investors respond to cooler inflation signals from Europe and easing bond yields. In Germany, June inflation sits at 2.8% for headline and 2.4% for core, meaning prices are rising but by less than economists expected, which can ease pressure on central banks to keep rates high. At the same...
NasdaqGS:PCVX
NasdaqGS:PCVXBiotechs

Should Early VAX-A1 Trial Progress Require Action From Vaxcyte (PCVX) Investors?

Vaxcyte, Inc. recently reported past progress in its early-stage clinical trial of VAX-A1, a Group A streptococcus vaccine candidate being tested for safety, tolerability and immune response in healthy young adults. A positive or negative read on this program could reshape how investors view Vaxcyte’s ability to expand beyond pneumococcal vaccines into another major infectious disease market. We’ll now examine how the early VAX-A1 clinical progress update may influence Vaxcyte’s existing...
NYSE:EE
NYSE:EEOil and Gas

Is Excelerate Energy (EE) A Bargain Following Its Russell Index Addition?

Excelerate Energy (EE) has been added to several Russell growth indexes, including the Russell 2000 and Russell 3000 series. This development may influence how index funds and institutional investors approach the stock. See our latest analysis for Excelerate Energy. Excelerate Energy's recent inclusion in multiple Russell growth indexes arrives after a strong period for the stock, with a 30 day share price return of 20.14% and a year to date share price return of 36.63%, while the 1 year...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Russell Value Index Additions Could Be A Game Changer For Beam Therapeutics (BEAM)

In late June 2026, Beam Therapeutics Inc. (NasdaqGS: BEAM) was added to several Russell Value benchmarks, including the Russell 3000E, 3000, 2500, 2000, and Small Cap Comp indices. This broad inclusion across the Russell Value family can influence trading activity as index-tracking funds and value-focused investors adjust their portfolios to reflect the new constituent. Now we'll examine how Beam’s broad inclusion in Russell Value indices may shape its investment narrative around gene...
NasdaqGS:ANDE
NasdaqGS:ANDEConsumer Retailing

How Broad Russell Growth Index Additions At Andersons (ANDE) Have Changed Its Investment Story

On 27 June 2026, The Andersons, Inc. was added to multiple Russell growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Small Cap Comp Growth, and 2000 Growth-Defensive indices. This cluster of index inclusions can meaningfully broaden Andersons’ investor base as passive and benchmark-aware funds adjust their holdings to reflect the changes. We’ll now examine how Andersons’ broad Russell growth index additions might reinforce or challenge the...
NasdaqGS:OLED
NasdaqGS:OLEDSemiconductor

Does Universal Display (OLED) Pairing Sector Tailwinds With OLED Leadership Strengthen Its Long-Term Moat?

Recently, Universal Display Corporation gained attention as the broader semiconductor sector recovered on upbeat Wall Street commentary and new multi-year supply agreements. At the same time, Executive Vice President and Chief Technical Officer Dr. Julie Brown received the prestigious IEEE Frederik Philips Award, highlighting Universal Display’s leadership in phosphorescent OLED innovation and its role in the shift from LCDs to more power-efficient OLED displays. We’ll now explore how...
NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

Is Amylyx Pharmaceuticals (AMLX) A Bargain Following Russell Index Removals?

Amylyx Pharmaceuticals (AMLX) has just been removed from several Russell equity indexes, a technical event that can prompt index tracking funds to adjust holdings and influence short term trading patterns in the stock. See our latest analysis for Amylyx Pharmaceuticals. Despite the index removals and a 1-day share price return of 1.64% and 7-day share price return of 3.9% at the latest close of $17.97, Amylyx Pharmaceuticals still has a 30-day share price return of 34.91% and a year to date...
NYSE:BKV
NYSE:BKVOil and Gas

What BKV (BKV)'s Texas CCS Network Expansion Means For Shareholders

In late June 2026, BKV Corporation announced that its Eagle Ford carbon capture and sequestration facility in South Texas had started operations, joining the Barnett Zero and Cotton Cove projects to form a three-site commercial CCS network across Texas. This expansion, underpinned by BKV’s joint venture with Copenhagen Infrastructure Partners and the retention of environmental credits, underscores the company’s push to integrate carbon management with its natural gas and midstream...
NYSE:BORR
NYSE:BORREnergy Services

Borr Drilling (BORR) Could Be 22% Undervalued As Rig Deals Expand Its Fleet

Borr Drilling (BORR) has drawn fresh attention after completing a US$360 million acquisition of five premium jack up rigs from Noble Corporation and agreeing to acquire five additional rigs through a new joint venture. See our latest analysis for Borr Drilling. Borr Drilling’s share price, now at US$4.47, has seen mixed momentum, with a 7 day share price return of 6.18% but a 90 day share price return down 25.13%. At the same time, the 1 year total shareholder return of 113.88% and 5 year...
NYSE:KMT
NYSE:KMTMachinery

How Investors Are Reacting To Kennametal (KMT) Joining Russell Growth Indices And Revamping HR Leadership

Kennametal Inc. was recently added to multiple Russell growth indices, including the Russell 2000 Growth and Russell 3000 Growth, while also naming Amanda Cole as its new Chief Human Resources Officer, effective July 21, 2026, succeeding long-time HR leader Judith Bacchus upon her planned retirement around October 1, 2026. The simultaneous inclusion in several Russell benchmarks and the appointment of a CHRO overseeing global HR, communications and EHSQ functions together highlight how...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Is Liberty Latin America (LILA) A Bargain After Its Russell Index Additions?

Index additions put Liberty Latin America on more investor radars Liberty Latin America (NasdaqGS:LILA) has been added to several Russell growth benchmarks, including the Russell 2000 and 3000 Growth indices. This change may influence how many institutional investors track the stock. See our latest analysis for Liberty Latin America. At a share price of $7.53, Liberty Latin America has seen its momentum cool in recent months, with the 90 day share price return down 9.17%, even as the 1 year...
NYSE:PNFP
NYSE:PNFPBanks

How Investors May Respond To Pinnacle Financial Partners (PNFP) Russell Growth Inclusion and ESOP Stock Offering

Pinnacle Financial Partners recently appointed veteran Orlando banker Michael McClanahan as its Orlando regional president and was added to multiple Russell Growth benchmarks, while also filing a US$7.58 million common stock shelf registration for an ESOP-related offering. These moves expand leadership depth in Central Florida and increase the bank’s visibility with institutional investors that track or benchmark against Russell Growth indices. We’ll now examine how Pinnacle’s inclusion in...
NYSE:CNR
NYSE:CNROil and Gas

DOE-Backed Rare Earths Pilot Using Coal Waste Might Change The Case For Investing In Core (CNR)

Core Natural Resources has announced that its subsidiary CONSOL Innovations LLC was selected by the U.S. Department of Energy for a multi-million-dollar grant to build a pilot facility at the Pennsylvania Mining Complex to recover rare earth elements and other critical minerals from coal waste tailings. This project highlights how Core may potentially repurpose coal byproducts into higher-value critical materials that are important for U.S. supply chain security and advanced technologies. We...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

Is Tango Therapeutics (TNGX) Fully Valued On Russell Index Rebalancing?

Tango Therapeutics (TNGX) is at the center of index rebalancing after being added to several Russell growth benchmarks and removed from various value and microcap indexes, a mix that can reshape short term trading flows. See our latest analysis for Tango Therapeutics. Tango Therapeutics has seen a sharp shift in momentum, with the share price up 48.07% over the past month and a 235.27% year to date share price return, alongside a very large 1 year total shareholder return of 451.38%. This...
NYSE:PAG
NYSE:PAGSpecialty Retail

What Penske Automotive Group (PAG)'s Margin Squeeze and EPS Decline Means For Shareholders

Recent commentary on Penske Automotive Group has highlighted that, despite higher revenue in recent years, weak same-store sales trends and intense competition have compressed dealership gross margins, contributing to an annual 10.6% decline in earnings per share. This contrast between rising sales and shrinking earnings has raised fresh questions about how profitable and resilient Penske’s growth really is across its core markets. We’ll now examine how pressure on same-store sales and...
NYSE:ECG
NYSE:ECGConstruction

Everus Construction Group (ECG) Joins Russell Growth Indexes As Valuation Debate Heats Up

Everus Construction Group (ECG) has been added to several Russell Growth benchmarks, including the Russell 1000 Growth, Russell 2500 Growth, and Russell Midcap Growth indices, a change that may affect index fund and ETF trading activity. See our latest analysis for Everus Construction Group. Everus Construction Group’s recent index additions come after a sharp 1 year total shareholder return of 123.56%, alongside a 61.31% year to date share price return. However, the 7 day share price return...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

The Bull Case For Zenas BioPharma (ZBIO) Could Change Following Its Shift Into Russell Growth Indices

In late June 2026, Zenas BioPharma was removed from several Russell value benchmarks and simultaneously added to multiple Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices. This broad shift from value to growth classifications highlights how index providers now categorize Zenas BioPharma more squarely as a growth-oriented biotech name. Next, we’ll explore how this reclassification into growth indices and the resulting index-tracking fund activity...